The effectiveness of immunization of children against Pneumococcal infection in Penza, Russia
https://doi.org/10.22627/2072-8107-2019-18-1-34-37
Abstract
The urgency of the problem is due to the fact that respiratory diseases occupy one of the first places in the structure of child morbidity, and community-acquired pneumonia remains one of the main causes of hospitalization and mortality among children. Streptococcus pneumonia remains the leading bacterial etiological agent of community-acquired pneumonia in the total population of pathogens.
The article presents a statistical study of the impact of vaccination against pneumococcus on the incidence of community-acquired pneumonia in children in Penza, Russia. It was revealed that the incidence of community-acquired pneumonia in children vaccinated with 1 3-valent conjugate pneumococcal vaccine is 3.2 times lower than in unvaccinated children.
About the Authors
O. N. LesinaRussian Federation
Olga Lesina - PhD, associate professor of department of infectious diseases
N. V. Golovina
Russian Federation
NadezhdaGolovina
Penza
I. P. Baranova
Russian Federation
IrinaBaranova
V. A. Kalinkina
Russian Federation
Valentina Kalinkina
Penza
L. S. Ettinger
Russian Federation
Lyudmila Etinger
Penza
References
1. Kladova O.V, T.F. Pogodina, E.V Zamakhina, V.F. Uchaykin. The problem of flu today and tomorrow. Detskie infektsii. = Children's infections. 2007. 3: 54-60. (In Russ.)
2. Community-acquired pneumonia in children. Clinical recommendations. The ed. A.G. Chuchalin. M., 2015: 64. (In Russ.)
3. Respiratory tract infections. Epidemiological surveillance of community-acquired pneumonia: Methodical instructions, dated January 10, 2013. ME 3.1.2.3047-1 3. M., 2013: 42. (In Russ.)
4. Principi N., Esposito S. Management of severe community-acquired pneumonia of children in developing and developed countries. Thorax. 2011; 66: 815-822.
5. Tatochenko V Diseases of the respiratory system in children: A practical guide. M., 2015: 395. (In Russ.)
6. Guchev I.A., Klochkov O.I., Sinopalnikov A.I. Preventing outbreaks of community-acquired pneumonia with a polysaccharide pneumococcal vaccine: an analysis of the prospects for use in power structures of Russia. Antibiotiki i Khimioterapiya = Antibiotics and Chemotherapy. 2016. 1: 43-52. (In Russ.)
7. Namazova-Baranova L.S., T.V Kulichenko, A.E. Malakhova, E.V Staro-voytova et al. Pneumococcal pneumonia in children: lessons in daily practice. Vopr. sovr. pediatrics. 2012. 4: 65-72. (In Russ.)
8. Karneeva J.N., I.P. Baranova, O.N. Lesina et al. Etiological characteristics and clinical features of pneumonia in children: A training manual for doctors. Penza, 2015: 96. (In Russ.)
9. Holter J.C., Muller F, Bjorang O et al. Etiology of Community-acquired pneumonia and diagnostic yields of microbiological methods: a 3-year prospective study in Norway. BMC Infect Dis. 2015;15:64.
10. On approval of the national calendar of preventive vaccinations and the calendar of preventive vaccinations for epidemic indications. Order of the Ministry of Health of the Russian Federation dated March 21, 2014 №125 n. (In Russ.)
11. Hausdorff W.P., Bryant J., Paradiso P.R., Siber G.R. Wich pneumococcal serogroups cause the most invasive diseases: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000; 30(1):100-121.
12. Mayanskiy N., Alyabieva N., Ponomarenko o et al. Bacterial etiology of acute otitis media and characterization of pneumococcal serotypes and genotypes among children in Moscow, Russia. Pediat Infect Dis J. 2015; 34(3): 255-260.
Review
For citations:
Lesina O.N., Golovina N.V., Baranova I.P., Kalinkina V.A., Ettinger L.S. The effectiveness of immunization of children against Pneumococcal infection in Penza, Russia. CHILDREN INFECTIONS. 2019;18(1):34-37. (In Russ.) https://doi.org/10.22627/2072-8107-2019-18-1-34-37